Abstract
Recent evidence from a randomized clinical trial has re-evaluated the benefit of intra-aortic balloon pump (IABP) in patients with STEMI complicated by cardiogenic shock, leading to a downgrading of the recommendation level in the international guidelines. The aim of our study was to evaluate the
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
